![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61P 29/00 | |
A61P 3/00 | |||
A61K 38/17 | |||
A61L 31/16 | |||
A61K 9/06 | |||
A61L 27/00 | |||
A61K 38/07 |
(11) | Number of the document | 2504035 |
(13) | Kind of document | T |
(96) | European patent application number | 10830687.9 |
Date of filing the European patent application | 2010-11-10 | |
(97) | Date of publication of the European application | 2012-10-03 |
(45) | Date of publication and mention of the grant of the patent | 2019-03-27 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2010/056277 |
Date | 2010-11-10 |
(87) | Number | WO 2011/060104 |
Date | 2011-05-19 |
(30) | Number | Date | Country code |
25974809 P | 2009-11-10 | US |
(72) |
MACKEL, Michael, John, US
PARK, John, US
|
(73) |
Allegro Pharmaceuticals, LLC,
31103 Rancho Viejo Road, No. 2249, San Juan Capistrano, CA 92675,
US
|
(54) | COMPOSITIONS AND METHODS FOR INHIBITING CELLULAR ADHESION OR DIRECTING DIAGNOSTIC OR THERAPEUTIC AGENTS TO RGD BINDING SITES |
COMPOSITIONS AND METHODS FOR INHIBITING CELLULAR ADHESION OR DIRECTING DIAGNOSTIC OR THERAPEUTIC AGENTS TO RGD BINDING SITES |